Published in Am J Epidemiol on April 09, 2007
Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57
Biological markers of sexual activity: tools for improving measurement in HIV/sexually transmitted infection prevention research. Sex Transm Dis (2013) 1.24
Good performance of rapid prostate-specific antigen test for detection of semen exposure in women: implications for qualitative research. Sex Transm Dis (2009) 1.16
Translation of biomedical prevention strategies for HIV: prospects and pitfalls. J Acquir Immune Defic Syndr (2013) 1.12
Determinants of condom breakage among female sex workers in Karnataka, India. BMC Public Health (2011) 0.97
Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance. Contraception (2012) 0.87
Vaginal swab specimen processing methods influence performance of rapid semen detection tests: a cautionary tale. Contraception (2010) 0.86
Interventions to prevent sexually transmitted infections, including HIV infection. Clin Infect Dis (2011) 0.86
Promoting female condoms in the sex industry in 4 towns of Southern China: context matters. Sex Transm Dis (2013) 0.85
Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studies. Contraception (2012) 0.85
Do women using long-acting reversible contraception reduce condom use? A novel study design incorporating semen biomarkers. Infect Dis Obstet Gynecol (2011) 0.78
Baseline correlates of inconsistent and incorrect condom use among sexually active women in the contraceptive CHOICE Project. Sex Transm Dis (2011) 0.78
Prostate-specific antigen is unlikely to be a suitable biomarker of semen exposure from recent unprotected receptive anal intercourse in men who have sex with men. Sex Transm Dis (2014) 0.77
The constraints and concerns regarding the size and/or shape of the second generation female condom: The narratives from the healthcare providers. Afr J Prim Health Care Fam Med (2016) 0.75
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet (2008) 19.65
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med (2010) 8.51
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet (2012) 6.78
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48
Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med (2009) 5.35
Pregnancy and infection. N Engl J Med (2014) 4.15
Parent and physician attitudes regarding electronic communication in pediatric practices. Pediatrics (2002) 3.87
Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol (2007) 3.86
Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS (2006) 3.70
A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology (2006) 3.68
Fertility treatments and multiple births in the United States. N Engl J Med (2013) 3.45
Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (2007) 3.22
An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity. Matern Child Health J (2007) 2.89
Rapid HIV-1 testing during labor: a multicenter study. JAMA (2004) 2.81
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
Pandemic influenza and pregnant women. Emerg Infect Dis (2008) 2.80
Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings. Lancet (2005) 2.73
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med (2011) 2.71
Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol (2010) 2.69
Tubal factor infertility and perinatal risk after assisted reproductive technology. Obstet Gynecol (2013) 2.66
Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. J Acquir Immune Defic Syndr (2002) 2.48
Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials (2008) 2.35
Interim Guidelines for Pregnant Women During a Zika Virus Outbreak - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 2.27
Efficacy of the female condom as a barrier to semen during intercourse. Am J Epidemiol (2003) 2.20
Severe obstetric morbidity in the United States: 1998-2005. Obstet Gynecol (2009) 2.16
Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol (2008) 2.12
Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health (2009) 2.09
The health of HIV-exposed children after early weaning. Matern Child Nutr (2011) 2.01
Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care (2010) 1.94
Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis (2006) 1.93
Partner characteristics, intensity of the intercourse, and semen exposure during use of the female condom. Am J Epidemiol (2003) 1.92
The acceptability of the female and male condom: a randomized crossover trial. Perspect Sex Reprod Health (2004) 1.90
Trends and outcomes for donor oocyte cycles in the United States, 2000-2010. JAMA (2013) 1.90
Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol (2006) 1.88
HIV seroprevalence among orphaned and homeless youth: no place like home. AIDS (2012) 1.76
Maternal mortality among Afghan refugees in Pakistan, 1999-2000. Lancet (2002) 1.74
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J Clin Invest (2011) 1.73
The use of nonhuman primate models in HIV vaccine development. PLoS Med (2008) 1.73
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Detection of two biological markers of intercourse: prostate-specific antigen and Y-chromosomal DNA. Contraception (2013) 1.68
Assisted reproductive technology surveillance -- United States, 2010. MMWR Surveill Summ (2013) 1.64
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Curr Opin HIV AIDS (2010) 1.63
Is there a trend of increased unwanted childbearing among young women in the United States? J Adolesc Health (2008) 1.63
Teen-Longitudinal Assessment of Bariatric Surgery: methodological features of the first prospective multicenter study of adolescent bariatric surgery. J Pediatr Surg (2007) 1.61
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission. Clin Infect Dis (2012) 1.56
HIV seroprevalence in street youth, St. Petersburg, Russia. AIDS (2007) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions. Am J Obstet Gynecol (2007) 1.55
Obstructive sleep apnea: Should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg (2006) 1.51
Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol (2002) 1.50
States Monitoring Assisted Reproductive Technology (SMART) Collaborative: data collection, linkage, dissemination, and use. J Womens Health (Larchmt) (2013) 1.49
Assisted reproductive technology surveillance--United States, 2009. MMWR Surveill Summ (2012) 1.49
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population. Obstet Gynecol (2015) 1.48
Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006. Obstet Gynecol (2010) 1.46
Safe conception for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol (2013) 1.45
Seroprevalence of human herpesvirus 8 infection in Northern Thailand. Clin Infect Dis (2004) 1.45
Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi. Contemp Clin Trials (2006) 1.45
Low absolute neutrophil counts in african infants. J Int Assoc Physicians AIDS Care (Chic) (2005) 1.44
Infertility services reported by men in the United States: national survey data. Fertil Steril (2008) 1.42
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016. MMWR Morb Mortal Wkly Rep (2016) 1.41
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
HIV-HBV coinfection--a global challenge. N Engl J Med (2012) 1.36
Estimates of HIV prevalence in a highly endemic area of China: Dehong Prefecture, Yunnan Province. Int J Epidemiol (2008) 1.35
Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis (2002) 1.35
Ectopic pregnancy risk with assisted reproductive technology procedures. Obstet Gynecol (2006) 1.34
Effects of influenza on pregnant women and infants. Am J Obstet Gynecol (2012) 1.32
Differences between international recommendations on breastfeeding in the presence of HIV and the attitudes and counselling messages of health workers in Lilongwe, Malawi. Int Breastfeed J (2006) 1.32
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003. AIDS (2006) 1.29
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
A national study of socioeconomic status and tuberculosis rates by country of birth, United States, 1996-2005. BMC Public Health (2012) 1.26
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads. J Acquir Immune Defic Syndr (2008) 1.26
Biological markers of sexual activity: tools for improving measurement in HIV/sexually transmitted infection prevention research. Sex Transm Dis (2013) 1.24
Trends and correlates of good perinatal outcomes in assisted reproductive technology. Obstet Gynecol (2012) 1.23
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Health outcomes of HIV-exposed uninfected African infants. AIDS (2013) 1.21
Breast milk and HIV-1: vector of transmission or vehicle of protection? Lancet Infect Dis (2003) 1.20
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol (2006) 1.20
Survival of blood donors and their spouses with HIV-1 subtype E (CRF01 A_E) infection in northern Thailand, 1992-2007. AIDS (2007) 1.19
A comparison of heterotopic and intrauterine-only pregnancy outcomes after assisted reproductive technologies in the United States from 1999 to 2002. Fertil Steril (2006) 1.19
A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr (2012) 1.18